| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €426.6M | +0.6% |
| Gross Profit | — | — |
| EBITDA | €79.7M | −5.0% |
| Net Income | €25.7M | −18.4% |
| Diluted EPS | €0.67 | −18.3% |
| Free Cash Flow | €50.6M | +54.3% |
| Ratio | 2024 | 2025 | Trend · 2y | vs own |
|---|---|---|---|---|
| ▾Margins | ||||
| Operating Margin | 9.55% | 8.02% | 25% | |
| EBITDA Margin | 19.79% | 18.68% | 25% | |
| NOPAT Margin | 7.74% | 6.55% | 25% | |
| Net Margin | 7.43% | 6.02% | 25% | |
| FCF Margin | 7.74% | 11.86% | 75% | |
| FCFF Margin | 8.67% | 12.80% | 75% | |
| FCFE Margin | 7.60% | 11.65% | 75% | |
| OCF Margin | 17.46% | 17.21% | 25% | |
| Capex Intensity | 9.72% | 5.34% | 25% | |
| ▸Returns on Capital · 6 ratios | ||||
| ▸DuPont factors (ROE drivers) · 4 ratios | ||||
| ▸Earnings quality · 7 ratios | ||||
| ▸Liquidity & coverage · 9 ratios | ||||
| ▸Leverage · 9 ratios | ||||
| ▸Working capital · 3 ratios | ||||
| ▸Capital allocation · 1 ratios | ||||
| ▸Other · 1 ratios | ||||
The five drivers multiply to 15.7% vs reported ROE 12.1%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2024 | 2025 |
|---|---|---|
| Revenue | €423.9M | €426.6M |
| YoY % | +0.6% | |
| Operating Income | €40.5M | €34.2M |
| YoY % | -15.6% | |
| Interest Expense | €4.9M | €4.9M |
| YoY % | 0.0% | |
| Interest & Investment Income | €100,000 | €200,000 |
| YoY % | +100.0% | |
| Equity Method Income | €3.2M | €1.9M |
| YoY % | -40.6% | |
| Pretax Income | €38.9M | €31.6M |
| YoY % | -18.8% | |
| Income Tax | €7.4M | €5.8M |
| YoY % | -21.6% | |
| Net Income (incl. NCI) | €31.5M | €25.7M |
| YoY % | -18.4% | |
| Net Income | €31.5M | €25.7M |
| YoY % | -18.4% | |
| EPS (Basic) | €0.83 | €0.67 |
| YoY % | -19.3% | |
| EPS (Diluted) | €0.82 | €0.67 |
| YoY % | -18.3% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
